By Beth Winegarner ( June 1, 2015, 5:50 PM EDT) -- A New Jersey federal judge found that Tyco Healthcare Group LP's patent suit over Mutual Pharmaceutical Company Inc.'s generic version of Restoril wasn't a sham, rejecting Mutual's antitrust counterclaim Friday after the Federal Circuit remanded the case for a second look at the allegations....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.